Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Transpact Enterprises Ltd operates in Medical Equipment & Supplies within the Healthcare sector.
311 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross margin % | — | -86.7% | 50% | — | — | 94.4% |
| EBITDA margin % | -133.3% | -133.3% | -7.9% | — | 50% | 66.7% |
| EBIT margin % | -266.7% | -160% | -18.4% | — | 0% | 44.4% |
| PAT margin % | -200% | -160% | -18.4% | — | 12.5% | 50% |
| Working capital | ||||||
| Receivable days | — | — | 0 | — | 0 | — |
| Inventory days | 939 | 13 | 19 | — | 91 | 0 |
| Payable days | — | — | 115 | — | 183 | — |
| NWC days | — | — | -96 | — | -91 | — |
| Leverage | ||||||
| Current ratio | 0.6 | 0.19 | 0.19 | 2.58 | 2.09 | 3 |
| Debt to EBITDA | — | — | — | — | 2.5 | — |
| Debt to equity | — | — | 0.52 | 0.11 | 0.22 | — |
| Interest coverage | — | — | — | — | — | — |
| Asset turnover | 0.02 | 0.14 | 0.37 | 0 | 0.11 | 0.23 |
| Return ratios | ||||||
| Return on assets % | -4.6% | -22.2% | -6.7% | -13.6% | 1.4% | 11.5% |
| Return on capital employed % | -5.5% | -30.3% | -12% | -19.4% | 0% | 15.7% |
| Return on equity % | — | — | -13% | -20% | 2.2% | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
| Holder (%) | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| 16.16% | 16.16% | 0.13% | 16.16% | |
| FII | 0% | 0% | 0% | 0% |
| DII | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% |
| 83.84% | 83.84% | 99.87% | 83.84% | |
| No. of shareholders | 143 | 129 | 123 | 122 |
Promoter holding up 0 percentage points since Sep 2024.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 17 Aug 2026 | JENISHA JAYESH MEHTA | Bulk | BSE | Sell | 2,000 | ₹96.00 | ₹0.02 Cr |
| 17 Aug 2026 | ENJORA VENTURES LLP | Bulk | BSE | Buy | 2,000 | ₹96.00 | ₹0.02 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Corporate actions, results dates and filings will appear here once ingested.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnostics LimitedMOLBIOMOLBIO | ₹17,431 Cr | ₹17,844 Cr | ₹1,020 Cr | ₹262 Cr | 25.7% | ₹145 Cr | 13.6% | 23.7% | 16.2% | — |
| Poly Medicure LimitedPOLYMEDPOLYMED | ₹16,610 Cr | ₹16,952 Cr | ₹1,997 Cr | ₹461 Cr | 23.6% | ₹315 Cr | 17.1% | 14.5% | 11% | 294 |
| Fischer Medical Ventures LimitedFISCHERFISCHER | ₹2,190 Cr | ₹2,262 Cr | ₹367 Cr | ₹50 Cr | 14% | ₹30 Cr | 10.1% | 13.6% | 8.6% | 111 |
| Tarsons Products LimitedTARSONSTARSONS | ₹1,752 Cr | ₹2,135 Cr | ₹441 Cr | ₹119 Cr | 27.9% | ₹11 Cr | 3.4% | 5% | 2.3% | 361 |
| Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL | ₹1,066 Cr | ₹1,066 Cr | ₹287 Cr | ₹46 Cr | 15.6% | ₹31 Cr | 10.4% | 14.7% | 12.8% | 109 |
| Hemant Surgical Industries LtdHSILHSIL | ₹885 Cr | — | ₹232 Cr | ₹23 Cr | 10% | ₹18 Cr | 7.9% | — | — | — |
| Fabtech Technologies LimitedFABTECHFABTECH | ₹632 Cr | ₹675 Cr | ₹418 Cr | ₹45 Cr | 8.5% | ₹49 Cr | 9.3% | 15.5% | 12.9% | 55 |
| Prevest Denpro LtdPREVESTPREVEST | ₹452 Cr | — | ₹72 Cr | ₹25 Cr | 34.4% | ₹20 Cr | 28.5% | — | — | — |
| Nureca LimitedNURECANURECA | ₹332 Cr | ₹333 Cr | ₹153 Cr | ₹4 Cr | 0.1% | ₹4 Cr | 1.4% | 3.3% | 1.1% | 186 |
| Earkart LtdEARKARTEARKART | ₹179 Cr | ₹179 Cr | ₹54 Cr | ₹8 Cr | 15.5% | ₹5 Cr | 9.1% | 12.1% | 7.7% | 243 |
| Choksi Asia LtdCHOKSICHOKSI | ₹117 Cr | ₹119 Cr | ₹11 Cr | ₹-2 Cr | 13.8% | ₹2 Cr | 10.8% | 18.9% | 13.5% | 142 |
| Shree Pacetronix LtdSHREEPACSHREEPAC | ₹68 Cr | ₹71 Cr | ₹8 Cr | ₹1 Cr | 23.5% | ₹0 Cr | 14% | 27.4% | 18.9% | 385 |
No scheme among the 32 fund houses on record reported a position in Transpact Enterprises Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Documents link to external sources (exchange filings, company investor pages).
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Intimation Of Closure Of Register Of Members & Share Transfer Books For The 13Th Annual General Meeting (AGM)
Notice Of 13Th Annual General Meeting To Be Held On 29Th September, 2026 At 04:00 P.M.
Reg. 34 (1) Annual Report.
Revised Outcome Of The Board Meeting Held On 4Th September, 2026 At 06:00 P.M.
Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th September, 2026 At 04:00 P.M.
Board Meeting Intimation for Board Meeting To Be Held On September 4, 2026 At 06:00 P.M.
| Date | Category | Subject | Filing |
|---|---|---|---|
| 30 Sept 2026, 6:41 pm | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | |
| 29 Sept 2026, 6:23 pm | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Outcome of AGM |
| 10 Sept 2026, 5:07 pm | Corp. Action Book Closure | Intimation Of Closure Of Register Of Members & Share Transfer Books For The 13Th Annual General Meeting (AGM) |
| 5 Sept 2026, 4:16 pm | AGM/EGM AGM | Notice Of 13Th Annual General Meeting To Be Held On 29Th September, 2026 At 04:00 P.M. |
| 5 Sept 2026, 4:02 pm | Others Reg. 34 (1) Annual Report | Reg. 34 (1) Annual Report. |
| 4 Sept 2026, 8:28 pm | Company Update General | Revised Outcome Of The Board Meeting Held On 4Th September, 2026 At 06:00 P.M. |
| 4 Sept 2026, 5:42 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th September, 2026 At 04:00 P.M. |
| 1 Sept 2026, 6:52 pm | Board Meeting | Board Meeting Intimation for Board Meeting To Be Held On September 4, 2026 At 06:00 P.M. |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | |
| COGS | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | — | -0 | 0 | — | — | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| -0 | -0 | -0 | -0 | 0 | 0 | |
| OPM % | -133.3% | -133.3% | -7.9% | — | 50% | 66.7% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | -0 | -0 | -0 | -0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | -0 |
| Tax % | 16.7% | 0% | 0% | 0% | — | -12.5% |
| -0 | -0 | -0 | -0 | 0 | 0 | |
| PAT margin % | -200% | -160% | -18.4% | — | 12.5% | 50% |
| EPS (₹) | -1.7 | -6.2 | -1.7 | 0 | 0 | 0.2 |
| EPS adjusted (₹) | — | — | -1.8 | -2.3 | 0.3 | — |
| Annual report | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | — | — | 0 | 0 | 0 | — |
| Reserves | — | — | 0 | 0 | 0 | — |
| — | — | 0 | 0 | 0 | — | |
| 1 | 1 | 0 | 0 | 0 | 1 | |
| Total equity & liabilities | 1 | 1 | 1 | 1 | 1 | 1 |
| — | — | 0 | — | 0 | 0 | |
| CWIP | — | — | 0 | — | 0 | — |
| Investments | 1 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 1 | 1 | 1 | 1 | |
| Total assets | 1 | 1 | 1 | 1 | 1 | 1 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 0 | -0 | 0 | 1 | -0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | -0 | |
| 0 | 0 | -0 | -0 | 0 | -0 | |
| Net cash flow | 0 | -0 | 0 | 0 | -0 | 0 |
| Free cash flow | 0 | -0 | 0 | 1 | -0 | 0 |
| CFO / Operating profit % | — | — | — | — | — | 150% |